Test Bank:
iw
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
iw iw iw iw iw iw iw iw i
w Edition, 2024
iw
, Table of Contents iw iw
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ...................................... 3
iw iw iw iw iw iw iw iw
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics ............................................................. 13
iw iw iw iw
Chapter4: Pharmacogenetics and Pharmacogenomics......................................................................... 25
iw iw iw
Chapter 5: Pharmacology Across the Life Span ............................................................................... 30
iw iw iw iw iw iw
Chapter 6: Drug-Therapy Prescribing in Special Populations ............................................................ 36
iw iw iw iw iw iw
Chapter 7: Drug Development and Approval.................................................................................... 45
iw iw iw iw iw
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
iw iw iw iw iw iw iw iw iw
Substance Prescribing Chapter 10: Antibiotic Stewardship ................................................................. 51
iw iw iw iw iw
Chapter 11: Applied Calculations for Prescribing ............................................................................. 58
iw iw iw iw iw
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
iw iw iw iw iw iw iw iw iw
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
iw iw iw iw iw iw iw iw iw iw iw
er 14: Pharmacotherapy for Eye Conditions ...................................................................................... 67
iw iw iw iw iw
Chapter 15: Pharmacotherapy for Skin Conditions ........................................................................... 74
iw iw iw iw iw
Chapter 16: Pharmacotherapy for Neurologic Conditions ................................................................. 81
iw iw iw iw iw
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ........................................................... 94
iw iw iw iw iw
Chapter 18: Pharmacotherapy for Respiratory Conditions .............................................................. 106
iw iw iw iw iw
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
iw iw iw iw iw iw iw iw iw
port ................................................................................................................................................ 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ........................................................... 128
iw iw iw iw iw
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ................... 133
iw iw iw iw iw iw iw iw iw
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions......................... 146
iw iw iw iw iw iw iw
Chapter 23: Therapeutic Applications of Immunology and Vaccines ............................................. 158
iw iw iw iw iw iw iw
Chapter 24: Pharmacotherapy for Endocrine Disorders................................................................... 163
iw iw iw iw iw
Chapter 25: Pharmacotherapy for Hematologic Disorders............................................................... 174
iw iw iw iw iw
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ............................. 190
iw iw iw iw iw iw iw iw
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .......................................... 196
iw iw iw iw iw iw iw
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions................................................ 211
iw iw iw iw iw iw iw
Chapter 29: Pharmacotherapy Related to Transgender Care ........................................................... 217
iw iw iw iw iw iw
Chapter 30: Antimicrobial Pharmacotherapy ................................................................................... 224
iw iw iw
Chapter 31: Antiretroviral Pharmacotherapy ................................................................................... 235
iw iw iw
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
iw iw iw iw iw iw iw iw iw iw
ocognitive Conditions...................................................................................................................... 247
iw
Chapter 33: Pharmacotherapy for Pain Management ...................................................................... 257
iw iw iw iw iw
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance................................. 267
iw iw iw iw iw iw iw iw iw
Chapter 35: Over-the-Counter Medications ..................................................................................... 283
iw iw iw
Chapter 36: Pharmacotherapy for Obesity ...................................................................................... 291
iw iw iw iw
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
iw iw iw iw iw iw iw iw
MULTIPLE CHOICE iw
• What is the primary purpose of the nursing assessment?
iw iw iw iw iw iw iw iw
A. Identifying underlying pathologic conditions iw iw iw
B. Assisting the physician in identifying medical conditions
iw iw iw iw iw iw
C. Determining the patients mental status iw iw iw iw
D. Exploring patient responses to health problems iw iw iw iw iw
ANS: D iw
A nursing assessment is done to identify the patients response to health
iw iw iw iw iw iw iw iw iw iw iw iw
problems. During the nursing assessment phase, a comprehensive inform
iw iw iw iw iw iw iw iw
ation base is developed through a physical examination, nursing history,
iw iw iw iw iw iw iw iw iw i
wmedication history, and professional observation. Identifying underlying
iw iw iw iw iw iw i
wpathologic conditions and assisting the physician in identifying medical
iw iw iw iw iw iw iw iw iw
conditions is not part of the nursing process. Determining the patients
iw iw iw iw iw iw iw iw iw iw iw
mental status is one part of the nursing assessment, but it is not the
iw iw iw iw iw iw iw iw iw iw iw iw iw i
wprimary purpose. iw
DIF: Cognitive Level: Comprehension
iw iw iw
REF: dm 36 OBJ: 1 | 3 TOP : Nursin
iw iw iw iw iw iw iw iw iw
g Process Step: Assessment
iw iw iw
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
iw iw iw iw iw iw iw iw
• What is the basis of the NANDA I taxonomy?
iw iw iw iw iw iw iw i w
A. Functional health patterns iw iw
B. Human response patterns iw iw
C. Basic human needs iw iw
D. Pathophysiologic needs iw
ANS: B iw
The NANDA I taxonomy identifies human response patterns. Fu
i w i w i w i w i w i w i w iw
nctional components of health patterns are limited to activity, fluid vol
iw iw iw iw iw iw iw iw iw iw
ume, nutrition, self care, and sensory perception. Basic human needs c
iw iw iw iw iw iw iw iw iw iw
omprise less than merely health patterns. Pathophysiologic needs are
iw iw iw iw iw iw iw iw i w
not part of the scope of NANDA I.
iw iw iw iw iw iw iw
, DIF: Cognitive Level: Knowledge RE
iw iw iw iw
F: pp. 37-38 OBJ: 5 TOP :
iw iw iw iw iw
Nursing Process Step: Diagnosis
iw iw iw
MSC: NCLEX Client Needs Category: Physiological Integrity
iw iw iw iw iw iw
• Which task is included in the assessment step of the nursing process?
iw iw iw iw iw iw iw iw iw iw iw
A. Establishing patient goals/outcomes iw iw
B. Implementing the nursing care plan (NCP) iw iw iw iw iw
C. Measuring goal/outcome achievement iw iw
D. Collecting and communicating data iw iw iw
ANS: D iw
Data are collected and communicated in the assessment phase of the nur
iw iw iw iw iw iw iw iw iw iw iw
sing process. Establishing goals is the function of planning.
iw iw iw iw iw iw iw iw
Implementing the NCP is the function of implementation. Measuring out
iw iw iw iw iw iw iw iw iw
come achievement is the function of evaluation.
iw iw iw iw iw iw
DIF: Cognitive Level: Comprehensio
iw iw iw
n REF: dm 36 OBJ: 2 | 3 TOP : Nursi
iw iw iw iw iw iw iw iw iw
ng Process Step: Assessment
iw iw iw
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
iw iw iw iw iw iw iw iw
• Which statement regarding nursing diagnoses is accurate?
iw iw iw iw iw iw
a. Nursing diagnoses remain the same for as long as the disease is present.
iw iw iw iw iw iw iw iw iw iw iw iw
b. Nursing diagnoses are written to identify disease states.
iw iw iw iw iw iw iw
c. Nursing diagnoses describe patient problems that nurses treat.
iw iw iw iw iw iw iw
d. Nursing diagnoses identify causes related to illness.
iw iw iw iw iw iw
ANS: C iw
Diagnostic statements identify problems a nurse is independently able t
iw iw iw iw iw iw iw iw iw
o treat within the scope of professional practice. Nursing diagnoses var
iw iw iw iw iw iw iw iw iw iw
y with the changing condition of the patient. The response patterns are
iw iw iw iw iw iw iw iw iw iw iw iw
unique to the patient and are not disease specific. Nursing diagnoses de
iw iw iw iw iw iw iw iw iw iw iw
scribe the patients human response pattern.
iw iw iw iw iw
DIF: Cognitive Level: Comprehension
iw iw iw
iw
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
iw iw iw iw iw iw iw iw i
w Edition, 2024
iw
, Table of Contents iw iw
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ...................................... 3
iw iw iw iw iw iw iw iw
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics ............................................................. 13
iw iw iw iw
Chapter4: Pharmacogenetics and Pharmacogenomics......................................................................... 25
iw iw iw
Chapter 5: Pharmacology Across the Life Span ............................................................................... 30
iw iw iw iw iw iw
Chapter 6: Drug-Therapy Prescribing in Special Populations ............................................................ 36
iw iw iw iw iw iw
Chapter 7: Drug Development and Approval.................................................................................... 45
iw iw iw iw iw
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
iw iw iw iw iw iw iw iw iw
Substance Prescribing Chapter 10: Antibiotic Stewardship ................................................................. 51
iw iw iw iw iw
Chapter 11: Applied Calculations for Prescribing ............................................................................. 58
iw iw iw iw iw
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
iw iw iw iw iw iw iw iw iw
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
iw iw iw iw iw iw iw iw iw iw iw
er 14: Pharmacotherapy for Eye Conditions ...................................................................................... 67
iw iw iw iw iw
Chapter 15: Pharmacotherapy for Skin Conditions ........................................................................... 74
iw iw iw iw iw
Chapter 16: Pharmacotherapy for Neurologic Conditions ................................................................. 81
iw iw iw iw iw
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ........................................................... 94
iw iw iw iw iw
Chapter 18: Pharmacotherapy for Respiratory Conditions .............................................................. 106
iw iw iw iw iw
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
iw iw iw iw iw iw iw iw iw
port ................................................................................................................................................ 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ........................................................... 128
iw iw iw iw iw
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ................... 133
iw iw iw iw iw iw iw iw iw
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions......................... 146
iw iw iw iw iw iw iw
Chapter 23: Therapeutic Applications of Immunology and Vaccines ............................................. 158
iw iw iw iw iw iw iw
Chapter 24: Pharmacotherapy for Endocrine Disorders................................................................... 163
iw iw iw iw iw
Chapter 25: Pharmacotherapy for Hematologic Disorders............................................................... 174
iw iw iw iw iw
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ............................. 190
iw iw iw iw iw iw iw iw
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .......................................... 196
iw iw iw iw iw iw iw
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions................................................ 211
iw iw iw iw iw iw iw
Chapter 29: Pharmacotherapy Related to Transgender Care ........................................................... 217
iw iw iw iw iw iw
Chapter 30: Antimicrobial Pharmacotherapy ................................................................................... 224
iw iw iw
Chapter 31: Antiretroviral Pharmacotherapy ................................................................................... 235
iw iw iw
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
iw iw iw iw iw iw iw iw iw iw
ocognitive Conditions...................................................................................................................... 247
iw
Chapter 33: Pharmacotherapy for Pain Management ...................................................................... 257
iw iw iw iw iw
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance................................. 267
iw iw iw iw iw iw iw iw iw
Chapter 35: Over-the-Counter Medications ..................................................................................... 283
iw iw iw
Chapter 36: Pharmacotherapy for Obesity ...................................................................................... 291
iw iw iw iw
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
iw iw iw iw iw iw iw iw
MULTIPLE CHOICE iw
• What is the primary purpose of the nursing assessment?
iw iw iw iw iw iw iw iw
A. Identifying underlying pathologic conditions iw iw iw
B. Assisting the physician in identifying medical conditions
iw iw iw iw iw iw
C. Determining the patients mental status iw iw iw iw
D. Exploring patient responses to health problems iw iw iw iw iw
ANS: D iw
A nursing assessment is done to identify the patients response to health
iw iw iw iw iw iw iw iw iw iw iw iw
problems. During the nursing assessment phase, a comprehensive inform
iw iw iw iw iw iw iw iw
ation base is developed through a physical examination, nursing history,
iw iw iw iw iw iw iw iw iw i
wmedication history, and professional observation. Identifying underlying
iw iw iw iw iw iw i
wpathologic conditions and assisting the physician in identifying medical
iw iw iw iw iw iw iw iw iw
conditions is not part of the nursing process. Determining the patients
iw iw iw iw iw iw iw iw iw iw iw
mental status is one part of the nursing assessment, but it is not the
iw iw iw iw iw iw iw iw iw iw iw iw iw i
wprimary purpose. iw
DIF: Cognitive Level: Comprehension
iw iw iw
REF: dm 36 OBJ: 1 | 3 TOP : Nursin
iw iw iw iw iw iw iw iw iw
g Process Step: Assessment
iw iw iw
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
iw iw iw iw iw iw iw iw
• What is the basis of the NANDA I taxonomy?
iw iw iw iw iw iw iw i w
A. Functional health patterns iw iw
B. Human response patterns iw iw
C. Basic human needs iw iw
D. Pathophysiologic needs iw
ANS: B iw
The NANDA I taxonomy identifies human response patterns. Fu
i w i w i w i w i w i w i w iw
nctional components of health patterns are limited to activity, fluid vol
iw iw iw iw iw iw iw iw iw iw
ume, nutrition, self care, and sensory perception. Basic human needs c
iw iw iw iw iw iw iw iw iw iw
omprise less than merely health patterns. Pathophysiologic needs are
iw iw iw iw iw iw iw iw i w
not part of the scope of NANDA I.
iw iw iw iw iw iw iw
, DIF: Cognitive Level: Knowledge RE
iw iw iw iw
F: pp. 37-38 OBJ: 5 TOP :
iw iw iw iw iw
Nursing Process Step: Diagnosis
iw iw iw
MSC: NCLEX Client Needs Category: Physiological Integrity
iw iw iw iw iw iw
• Which task is included in the assessment step of the nursing process?
iw iw iw iw iw iw iw iw iw iw iw
A. Establishing patient goals/outcomes iw iw
B. Implementing the nursing care plan (NCP) iw iw iw iw iw
C. Measuring goal/outcome achievement iw iw
D. Collecting and communicating data iw iw iw
ANS: D iw
Data are collected and communicated in the assessment phase of the nur
iw iw iw iw iw iw iw iw iw iw iw
sing process. Establishing goals is the function of planning.
iw iw iw iw iw iw iw iw
Implementing the NCP is the function of implementation. Measuring out
iw iw iw iw iw iw iw iw iw
come achievement is the function of evaluation.
iw iw iw iw iw iw
DIF: Cognitive Level: Comprehensio
iw iw iw
n REF: dm 36 OBJ: 2 | 3 TOP : Nursi
iw iw iw iw iw iw iw iw iw
ng Process Step: Assessment
iw iw iw
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
iw iw iw iw iw iw iw iw
• Which statement regarding nursing diagnoses is accurate?
iw iw iw iw iw iw
a. Nursing diagnoses remain the same for as long as the disease is present.
iw iw iw iw iw iw iw iw iw iw iw iw
b. Nursing diagnoses are written to identify disease states.
iw iw iw iw iw iw iw
c. Nursing diagnoses describe patient problems that nurses treat.
iw iw iw iw iw iw iw
d. Nursing diagnoses identify causes related to illness.
iw iw iw iw iw iw
ANS: C iw
Diagnostic statements identify problems a nurse is independently able t
iw iw iw iw iw iw iw iw iw
o treat within the scope of professional practice. Nursing diagnoses var
iw iw iw iw iw iw iw iw iw iw
y with the changing condition of the patient. The response patterns are
iw iw iw iw iw iw iw iw iw iw iw iw
unique to the patient and are not disease specific. Nursing diagnoses de
iw iw iw iw iw iw iw iw iw iw iw
scribe the patients human response pattern.
iw iw iw iw iw
DIF: Cognitive Level: Comprehension
iw iw iw
